2016 Symposium Women's Cancers in the Americas: Strategies for Synergy

WOMEN-CANCERS-AMERICAS-KNAUL-125x77.jpg

THE FRAMEWORK FOR INTEGRATION

Felicia Marie Knaul
A Diagonal Approach
WOMEN-CANCERS-AMERICAS-FRENK-125x77.jpg

KEY NOTE SPEECH

Women, Cancer and Health Systems
Julio Frenk
WOMEN-CANCERS-AMERICAS-KNAUL-125x77.jpg

THE FRAMEWORK FOR INTEGRATION

Felicia Marie Knaul
A Diagonal Approach

WOMEN-CANCERS-AMERICAS-FRENK-125x77.jpg

KEY NOTE SPEECH

Women, Cancer and Health Systems
Julio Frenk

Breast and cervical cancer are leading killers of women throughout the world. In most of Latin America and the Caribbean, breast and cervical cancer are among the most common causes of death for younger women. Both diseases are preventable or curable if diagnosed and treated early, yet responses have been fragmented, missing the tremendous opportunities for collective, hemispheric action across countries, disciplines, governmental and non-governmental actors, academia, clinicians and civil society.

“Closing divides around women´s cancer is a health, equity and economic imperative; affordable and achievable through diagonal approaches.”

Felicia Marie Knaul

VIDEOS

WOMEN-CANCERS-AMERICAS-LANGER-480x320.jpg
Play Video Button

The Framework for Integration

“How to integrate the approaches so the work of these women become more effective and the work of everyone in the health care sector becomes more effective? This is critical and urgent.”

 

Dr. Ana Langer

Director of the Women and Health Initiative

Harvard University

WOMEN-CANCERS-AMERICAS-LANGER-480x320.jpg
Play Video Button
WOMEN-CANCERS-AMERICAS-PRAH-480x320.jpg
Play Video Button

The Ethical Framework for Health Equity

“…Why isn’t there more of a sense of outrage? (…) One way of thinking about ethics in health towards an integrated approach (…) is to think of the current status as a collective failure on the part of the international community to meet the most basic needs.” 

 

Dr. Jennifer Prah Ruger

Amartya Sen Professor of Health Equity, Economics and Policy University of Pennsylvania

WOMEN-CANCERS-AMERICAS-PRAH-480x320.jpg
Play Video Button
WOMEN-CANCERS-AMERICAS-COWALL-480x320.jpg
Play Video Button

Building Synergies across Women's Cancers

“Our opportunity here today cannot be overstated. We have highly effective prevention, early detection and treatment tools that have the potential to transform the lives of millions of women, and it is not a health issue, it is an equity issue, it is a human rights issue.” 

 

Ambassador Sally Cowal

Senior Vice President for Global Health

American Cancer Society

WOMEN-CANCERS-AMERICAS-COWALL-480x320.jpg
Play Video Button
WOMEN-CANCERS-AMERICAS-DE-LIMA-480x320.jpg
Play Video Button

What Role for Academic Medicine and Research?

“Early detection is essential to improving outcome.” 

 

Dr. Gilberto de Lima Lopes

Associate Director of Global Oncology

Sylvester Comprehensive Cancer Center

WOMEN-CANCERS-AMERICAS-DE-LIMA-480x320.jpg
Play Video Button
WOMEN-CANCERS-AMERICAS-SLOMOVITZ-480x320.jpg
Play Video Button

Gynecologic Oncology Fellowship

“We use a lot of robots here in South Florida. We are not looking to train Caribbean doctors on how to use  robots, because they don’t have any robots in the Caribbean. We are looking to train them in good surgical techniques.”

 

Dr. Brian Slomovitz

Co-leader of the Gynecologic Cancers Site Disease Group Sylvester Comprehensive Cancer Center

WOMEN-CANCERS-AMERICAS-SLOMOVITZ-480x320.jpg
Play Video Button

Breast Cancer in the United States

29%

Breast cancer is a leading killer of young women in developing countries and the most common cancer among US women, accounting for 29% of newly diagnosed cancers.

1 in 8

A woman living in the US has a 1 in 8, lifetime risk of being diagnosed with breast cancer.

231,840

An estimated number 231,840 new cases of invasive breast cancer will be diagnosed among women in 2015.

40,290

Approximately 40,290 women are expected to die from breast cancer in 2015. The number of deaths was 21.5 per 100,000 women per year.

5-year

The 5-year relative survival rate for female invasive breast cancer patients has improved from 75% in the mid-1970s to 90% today.

42%

As treatments for breast cancer have improved, the racial disparity has widened: by 2012, breast cancer death rates were 42% higher in black women than in white women.

The University of Miami Institute for Advanced Study of the Americas’ work on women´s cancers in the Americas and this Symposium are the result of visionary seed funding provided by Patti Herbert, B.B.A. ’57 and University of Miami Trustee Allan Herbert, B.B.A. ’55. The Herberts are dedicated long-time supporters and active members of the University of Miami community.

SYLVESTER-2-400x400.jpg

Sylvester Comprehensive Cancer Center

Since its inception as a dedicated, comprehensive cancer center, then significantly supported by a naming gift from the Harcourt M. and Virginia W. Sylvester Foundation, Sylvester Comprehensive Cancer Center has been the cancer brand for the University of Miami Leonard M. Miller School of Medicine
UMIA.jpg

Institute for Advanced Study of the Americas

Established in 2015, the University of Miami Institute for Advanced Study of the Americas brings together relevant scholarship, furthers policy dialogue, and builds strategic knowledge partnerships to address challenges faced by the Americas in the 21st century
MILLER-SCHOOL-OF-MEDICINE-2-400x400.jpg

University of Miami Miller School of Medicine

The mission of the Leonard M. Miller School of Medicine and the University of Miami Health System is to be a state-of-the-art academic medical center. This is accomplished by delivering high-quality, compassionate health care, leading life-changing discoveries and transforming patient care through innovative research
HARVARD-T.H.-CHAN-2-400x400.jpg

Harvard T.H. Chan School of Public Health

The overarching mission of the Harvard T.H. Chan School of Public Health is to advance the public’s health through learning, discovery, and communication. To pursue this mission, the School produces knowledge through research, reproduces knowledge through higher education, and translates knowledge into evidence
TOMATELO-A-PECHO-2-400x400.jpg

Tomatelo a Pecho

Tómatelo a Pecho is a Non-Governmental Organization committed to reducing breast cancer mortality, through early detection and effective treatment. It is also dedicated to identifying niches of action, key stakeholders and opportunities in order to implement innovative solutions to enable improvements of healthcare systems as well as the capacity of service providers to detect breast cancer in its early stages of development
ULACCAM-2-400x400.jpg

Union Latinoamericana contra el Cancer de la Mujer

The Latin American Union against Women’s Cancer (ULACCAM, for its Spanish acronym) is a coalition of non-governmental organizations from Latin America committed to promoting effective legislations and policies in the región related to women’s Cancers, mainly breast and cervical cancer
ACS-2-400x400.jpg

American Cancer Society

The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organization, the Society's efforts have contributed to a 20 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates
SUSAN-G.-KOMEN-2-400x400.jpg

Susan G. Komen

In 1980, Nancy G. Brinker promised her dying sister, Susan, that she would do everything in her power to end breast cancer forever. In 1982, that promise became the Susan G. Komen® organization and the beginning of a global movement. It has grown into the world’s largest nonprofit source of funding for the fight against breast cancer
BCRF-2-400x400.jpg

Breast Cancer Research Foundation

The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship